Celanese rises 5.0% after third-quarter results beat and upbeat outlook

What happened

Celanese (CE) rose 5.0% on November 3, 2026, because of third-quarter results that beat estimates and a raised 2026 outlook. The company reported third-quarter 2026 results and held an earnings call on November 3, 2026, saying pricing and commercial execution were strong and that Q3 exceeded guidance, according to Business Wire and Seeking Alpha.

How big was the move

The stock closed at $50.36 and rose 5.0% on the day, trading at 2.4 times its 20-day average volume. The session opened 5.5% above the previous close, and the day’s jump amounted to 2.2 times a typical daily move for the stock. Celanese outperformed the Basic Materials sector median by 6.2 percentage points on a day when the sector fell 1.2% and the S&P 500 rose 0.4%.

The S&P 500 was down 2.0% over the past five sessions while Celanese rose 3.6% in that span, leaving the stock relatively resilient versus the market. Market sensitivity measured a beta of 0.96, so the stock tends to move about as much as the market.

The technical picture

The stock sat 6.9% above its 20-day moving average and 9.1% above its 50-day moving average, while trading 2.4% below its 200-day moving average. The 50-day average remained below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) stood at 65, inside a neutral range.

Celanese was 28.8% below its 52-week high, but it had risen 10.6% over one month and 16.7% over three months, leaving it 31.0% higher over one year and 20.4 percentage points ahead of the S&P 500. Volatility measured 37% annualized over 60 days, lower than 53% of its own readings over five years, suggesting recent swings have been less extreme than some past episodes.

In the past five years the stock had 42 sessions with a gain of at least 5.0%. Twenty trading days later the median result was a gain of 0.5%, and 22 of 42 were higher.

Fundamentals and valuation

For the four quarters through September 30, 2026, revenue was $9.85 billion, up 1.4% from a year earlier, and diluted earnings per share were $2.37. Gross margin narrowed to 20.1% from 21.3% a year earlier, and operating margin fell to 8.0% from 23.5% a year earlier, reflecting a mix of cost and product-mix pressures even as pricing improved.

Free-cash-flow margin stood at 8.8% and return on invested capital at 3.8%. The balance sheet showed net debt of 6.4 times EBITDA, a level the company highlighted as it repositions for cash generation, cost savings and growth into higher-value materials amid ongoing raw-material and regional demand uncertainty. Share count over one year increased by 0.5%.

Valuation measures were mixed. The stock traded at 21.2 times trailing earnings, a reading higher than 93% of its own readings over the past five years, where the five-year median was 7.6 times earnings. Price to forward earnings was 8.4 times expected earnings and free-cash-flow yield was 16.0%.

PromtFinance scores showed Value at 70 (Positive) and Growth at 47 (Neutral). Quality was 36 (Weak) and Momentum was 56 (Neutral). Revisions came in at 13 (Very weak) and Stability at 22 (Very weak), indicating the market prices a premium while seeing weaknesses in revisions and stability.

Earnings and analyst expectations

Celanese reported earnings per share of $1.65 on November 2, 2026, against $1.56 expected, a 5.8% surprise above estimates. The company has now beaten consensus in two consecutive quarters. The average surprise over the last four reports was 3.4% below estimates, and the typical two-day reaction after recent reports was that the stock fell 1.0%.

Analysts’ consensus price target was $53.63, 6.5% above the closing price, based on 37 analysts covering the stock and a consensus rating of Hold; 30% of those ratings were Buy or Strong Buy. The next scheduled report was listed as November 5, 2026.

What to watch

• November 5, 2026: Next earnings-related event noted as the next report date
• Net debt of 6.4 times EBITDA as stated in the balance sheet
• Price to trailing earnings of 21.2 times trailing earnings versus the five-year median of 7.6 times earnings
• PromtFinance Revisions score of 13 (Very weak) and Stability score of 22 (Very weak)